Company Overview of Altheos, Inc.
Altheos, Inc. identifies and develops small molecule drugs for the treatment of glaucoma and ocular hypertension. The company develops ATS907 and ATS8535, a selective Rho kinase inhibitor for treatment of elevated intraocular pressure associated with glaucoma. The company was founded in 2009 and is based in South San Francisco, California.
601 Gateway Boulevard
South San Francisco, CA 94080
Founded in 2009
Key Executives for Altheos, Inc.
Similar Private Companies By Industry
|APE-BridgePath Scientific, LLC||United States|
|ACT Biotech, Inc.||United States|
|MK Stem Cell Inc.||United States|
|Alopexx Pharmaceuticals, LLC||United States|
|IMI International Medical Innovations, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Altheos, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.